Clinical Practice Guidelines
AAHKS has produced these guidelines specifically for hip and knee surgeons to use in their practices. Practice ResourcesAntirheumatic Drug Therapy
Description: Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty from AAHKS and the American College of Rheumatology.
Year released: 2017 – Updated 2022
Indications for Total Hip and Knee Replacement
Description: Indications for Total Hip and Knee Replacement from AAHKS and the American College of Rheumatology.
Year released: Final publication of guideline anticipated spring/summer 2023
Acetaminophen in TJA
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of acetaminophen following primary TJA.
Year released: 2020
NSAIDs in TJA
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of NSAIDs following primary TJA.
Year released: 2020
Gabapentinoids in TJA
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of gabapentinoids following primary TJA.
Year released: 2020
Opioids in TJA
Description:The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of opioids following primary TJA.
Year released: 2020
Tranexamic Acid in TJA
Description: The purpose of these guidelines is to improve the treatment of
orthopaedic surgical patients and reduce practice variation by promoting a
multidisciplinary evidence-based approach on the use of TXA.
Year released: 2018
